Abstract 452P
Background
Cancer is a serious disease, associated with significant morbidity and mortality. Despite the high burden of cancer, many risk factors have been linked to carcinogenesis. Some of them are preventable and with good awareness, they could be one of our tools in relieving that burden. Our study aimed to assess medical and paramedical students’ awareness of the environmental risk factors for cancer.
Methods
A web-based cross-sectional study was conducted among medical and para-medical students of Menoufia University. The data were collected from April to May 2022. We used a pre-validated questionnaire that was designed to address knowledge about different environmental risk factors for cancer.
Results
We obtained responses from 251 participants. The majority of respondents were medical students (n= 204; 81.3%), males (n= 157; 62.5%), and living in rural areas (n=160; 63.7%). Most participants (n=173; 68.9%) had a knowledge score of more than 50% with an average score of 24 out of 43 (24.22 ± 10.7). There was no Knowledge difference between medical and paramedical students (n=144; 70.6% vs n=29; 61.7%; p=0.237). Most students recognized radiation, smoking, and alcohol as risk factors for cancer (76.9%, 73.7%, and 70.7%). Regarding Vit D deficiency, paramedical students were more aware than medical students (51% vs 33,3%; p=0.023). However, a lower percentage acknowledged high red meat intake and low fiber diet (29.5%) as potential contributors to the occurrence of cancer.
Conclusions
There was good knowledge among medical and paramedical students about most of the environmental risk factors related to cancer pathogenesis. However, there was less awareness of diet-related ones, especially those related to colorectal cancer.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
399P - Role of denosumab as targeted therapy in treatment of unresectable or recurrent cases of giant cell tumor of the bone
Presenter: Anchal Mishra
Session: Poster viewing 06
400P - Phase I study of fianlimab, a human lymphocyte activation gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma (mel)
Presenter: Omid Hamid
Session: Poster viewing 06
401P - A phase Ib study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in combination with lenvatinib in patients (pts) with advanced solid tumors
Presenter: Shunsuke Kondo
Session: Poster viewing 06
402P - Phase I study of selumetinib in Chinese pediatric and adult patients (pts) with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN): Interim results
Presenter: Xiao-Jun Yuan
Session: Poster viewing 06
403P - Gender trend over time of principal investigators within large Australian cancer clinical trials groups
Presenter: Thi Thao Vi Luong
Session: Poster viewing 06
404P - Adolescent & young adult cancers (AYA): Experience from a large rural teaching hospital in South India
Presenter: Vishwapriya Godkhindi
Session: Poster viewing 06
405P - Evaluating medical oncology outcomes (EMOO) in Asia study: Diagnosis, staging, treatment patterns and outcome of patients with lung cancer registered 2017-2019
Presenter: Ross Soo
Session: Poster viewing 06
406P - Adrenal insufficiency induced by immune checkpoint inhibitors: Clinical characteristics of 145 cases
Presenter: kaoru koshiba
Session: Poster viewing 06
407P - A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan
Presenter: Naoya Yamazaki
Session: Poster viewing 06
408P - Machine learning for glioblastoma screening from histopathology whole slide imaging
Presenter: Eva Yi Wah Cheung
Session: Poster viewing 06